MA. ANTONIA
SALUD SALVIA
TEU
Hospital Obispo Polanco
Teruel, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Obispo Polanco (2)
2013
-
Phase ii study of irinotecan in combination with capecitabine on a 3-weekly schedule as first-line chemotherapy for patients with metastatic or locally advanced colorectal cancer
Journal of Analytical Oncology, Vol. 2, Núm. 3, pp. 151-159
2010
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146